Gene · 10747
Papers2,026
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,026
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the Roots of Kidney Disease: Systematic Review of the Therapies Targeting the Complement System. | Medicina (Kaunas) | 2025 | 40731834 | PubTator, text mining | PubMed |
| Nanostructured Protein Surfaces Inspired by Spider Silk. | Adv Mater | 2025 | 40722237 | PubTator, text mining | PubMed |
| [Study on the correlation between MASP-2 and diseases]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2025 | 40620125 | PubTator, text mining | PubMed |
| Intrinsic factors behind long COVID: exploring the role of nucleocapsid protein in thrombosis. | PeerJ | 2025 | 40416618 | PubTator, text mining | PubMed |
| Ficolin-3 Activates Complement and Triggers Necroptosis in Cholangiocarcinoma Cells via the RIPK1/RIPK3/MLKL Signaling Pathway. | FASEB J | 2025 | 40407231 | PubTator, text mining | PubMed |
| Kidney transplant in patients with C3 glomerulopathy. | Clin Kidney J | 2025 | 40385590 | PubTator, text mining | PubMed |
| Hypertension in Living Kidney Donors Has No Effect on Complement Activation and Fibrosis. | Kidney Blood Press Res | 2025 | 40341498 | PubTator, text mining | PubMed |
| Safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-2010, a novel anti-MASP-2 antibody, in healthy volunteers: a randomized, double-blind, placebo-controlled phase 1 study. | Expert Opin Investig Drugs | 2025 | 40297949 | PubTator, text mining | PubMed |
| Correlations of the Complement Proteins MASP-2 and MASP-3 With Clinical Severity and Short-Term Outcomes in Primary Membranous Nephropathy Patients. | Nephrology (Carlton) | 2025 | 40294883 | PubTator, text mining | PubMed |
| Targeting the complement lectin pathway with a highly specific MASP-2 inhibitor protects against renal ischemia-reperfusion injury. | Proc Natl Acad Sci U S A | 2025 | 40228118 | PubTator, text mining | PubMed |
| Host Response Protein Biomarkers Indicative of Persistent Acute Kidney Injury in Critically Ill COVID-19 Patients. | Crit Care Explor | 2025 | 40079888 | PubTator, text mining | PubMed |
| A novel 5-differentially expressed gene (DEG) signature predicting the prognosis in patients with metastatic liver malignancies and the prognostic and therapeutic potential of SPP1. | Int J Clin Oncol | 2025 | 40014188 | PubTator, text mining | PubMed |
| Small molecule inhibitors of mannan-binding lectin-associated serine Proteases-2 and-3. | Eur J Med Chem | 2025 | 40010268 | PubTator, text mining | PubMed |
| Complement proteins in axial spondyloarthritis: associations with disease activity and TNFi treatment response in a multicentre RCT. | Rheumatol Adv Pract | 2025 | 39959130 | PubTator, text mining | PubMed |
| Guianensin, a Blackfly Salivary Protein, Inhibits the Lectin Pathway of Complement. | J Med Chem | 2025 | 39924859 | Swiss-Prot, curated | PubMed |
| A possible association between low MBL/lectin pathway functionality and microbiota dysbiosis in endometriosis patients. | Life Sci | 2025 | 39892863 | PubTator, text mining | PubMed |
| Molecular Dynamics Study of the Structure and Mechanical Properties of Spider Silk Proteins. | Biomacromolecules | 2025 | 39748448 | PubTator, text mining | PubMed |
| The pathogenesis of IgA nephropathy and implications for treatment. | Nat Rev Nephrol | 2025 | 39232245 | PubTator, text mining | PubMed |
| Plasma proteomes of acute myeloid leukemia patients treated with transfusions reveal signatures of inflammation and hemostatic dysregulation. | Transl Med Commun | 2024 | 40078206 | PubTator, text mining | PubMed |
| p53/HIF-1α regulates neuronal aging and autophagy in spinal cord ischemia/reperfusion injury. | Mech Ageing Dev | 2024 | 39515667 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10747/papers?page=4